Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 4Hypoglycemia 2Glioblastoma 2Parkinsonian Disorders 1Parathyroid Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia 1Insulinoma 1Infant, Newborn, Diseases 1Hyperparathyroidism 1Hyperinsulinism 1Hypercalcemia 1Glucose Metabolism Disorders 1Brain Neoplasms 1

Interventions

Temozolomide 73Bevacizumab 57Radiotherapy 40Radiosurgery 28Carboplatin 23Nivolumab 17Etoposide 17Cisplatin 17pembrolizumab 16Irinotecan 16Ipilimumab 15Magnetic Resonance Spectroscopy 14Erlotinib Hydrochloride 14Cyclophosphamide 14Carmustine 14Pemetrexed 13Topotecan 10Surgical Procedures, Operative 10Capecitabine 10Lapatinib 9Filgrastim 9Trastuzumab 8Thalidomide 8Sunitinib 8Paclitaxel 8Lomustine 8Aminolevulinic Acid 8encorafenib 7binimetinib 7Vincristine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Brain Neoplasms × fluorodopa F 18 × Clear all
NCT06667726 2026-04-28

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Mayo Clinic

Phase 2 Recruiting
47 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡